Literature DB >> 16884977

Sevoflurane-remifentanil versus propofol-remifentanil anesthesia at a similar bispectral level for off-pump coronary artery surgery: no evidence of reduced myocardial ischemia.

Jean Dominique Law-Koune1, Catherine Raynaud, Ngai Liu, Claude Dubois, Mauro Romano, Marc Fischler.   

Abstract

OBJECTIVE: Sevoflurane could decrease myocardial ischemic injury in patients undergoing off-pump coronary artery bypass surgery. This study was designed to compare postoperative troponin I (cTnI) concentrations after sevoflurane-remifentanil versus propofol-remifentanil anesthesia.
DESIGN: Prospective, randomized single-blind clinical study.
SETTING: University hospital. PARTICIPANTS: Eighteen patients.
INTERVENTIONS: General anesthesia was conducted with sevoflurane-remifentanil (n = 9) or propofol-remifentanil (n = 9). Administration of sevoflurane and propofol was adjusted to maintain the bispectral index (BIS) between 40 and 60.
MEASUREMENTS AND MAIN RESULTS: Groups were comparable regarding the patients' characteristics. The objective of BIS was maintained in both groups except during the period of coronary artery grafts (p < 0.001) when the BIS number in the propofol group fell below 40 and was significantly lower than in the sevoflurane group. Intraoperative hemodynamic variables were similar between groups. No patient required cardiopulmonary bypass. Need for inotropic and vasoactive support during the first graft was not necessary in the propofol group and occurred in 4 patients in the sevoflurane group (not significant). During the second graft, 2 patients in the propofol group and 3 in the sevoflurane group needed hemodynamic support. Postoperative hemodynamic variables were comparable between groups. Areas under the curve of postoperative increases in cTnI were 27.0 +/- 38.6 and 17.4 +/- 14.6 ng/mL/hour in the sevoflurane and propofol groups, respectively (not significant).
CONCLUSION: This study does not support cardioprotective effects of sevoflurane. The particularly short total cumulative duration of ischemia and the relatively low administered end-tidal sevoflurane concentrations may explain this result.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884977     DOI: 10.1053/j.jvca.2005.08.001

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  9 in total

1.  Early cardioprotective effect of sevoflurane on left ventricular performance during coronary artery bypass grafting on a beating heart: randomized controlled study.

Authors:  Ino Huseidzinović; Stjepan Barisin; Nikola Bradić; Rudolf Milanović
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

2.  Effect of combination therapy of propofol and sevoflurane on MAP2K3 level and myocardial apoptosis induced by ischemia-reperfusion in rats.

Authors:  Yanqin Liu; Lei Shi; Chunyi Liu; Guiyun Zhu; Hao Li; Haitao Zhao; Suling Li
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Perioperative risk factors and cumulative duration of "triple-low" state associated with worse 30-day mortality of cardiac valvular surgery.

Authors:  Xin-Qi Cheng; Hao Wu; You-Mei Zuo; Bin Mei; Lei Zhang; Yu-Zhu Cai; Qing Zhao; Xian-Fu Lu; Xue-Sheng Liu; Er-Wei Gu
Journal:  J Clin Monit Comput       Date:  2016-03-05       Impact factor: 2.502

4.  Sevoflurane may be more beneficial than propofol in patients receiving endoscopic variceal ligation and endoscopic variceal sclerotherapy: A randomized, double-blind study.

Authors:  Linghua Tang; Huimin Liu; Yang Wu; Mei Li; Wei Li; Meng Jiang; Jiabao Hou; Ying Jiang; Zhongyuan Xia; Qingtao Meng
Journal:  Exp Ther Med       Date:  2017-08-09       Impact factor: 2.447

Review 5.  Myocardial conditioning techniques in off-pump coronary artery bypass grafting.

Authors:  Marco Moscarelli; Prakash P Punjabi; Gamov I Miroslav; Paolo Del Sarto; Francesca Fiorentino; Gianni D Angelini
Journal:  J Cardiothorac Surg       Date:  2015-01-20       Impact factor: 1.637

6.  Meta-analysis of the cardioprotective effect of sevoflurane versus propofol during cardiac surgery.

Authors:  Feng Li; Yuan Yuan
Journal:  BMC Anesthesiol       Date:  2015-09-24       Impact factor: 2.217

7.  Does the Type of Anesthetic Technique Affect In-Hospital and One-Year Outcomes after Off-Pump Coronary Arterial Bypass Surgery?

Authors:  Jeong Jin Min; Gahyun Kim; Jong-Hwan Lee; Kwan Young Hong; Wook Sung Kim; Young-Tak Lee
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

Review 8.  Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia.

Authors:  G Kunst; A A Klein
Journal:  Anaesthesia       Date:  2015-04       Impact factor: 6.955

9.  Circulating microRNAs indicate cardioprotection by sevoflurane inhalation in patients undergoing off-pump coronary artery bypass surgery.

Authors:  Xiao Liu; Xiaopeng Liu; Ruike Wang; Hui Luo; Gang Qin; L U Wang; Zhi Ye; Qulian Guo; E Wang
Journal:  Exp Ther Med       Date:  2016-03-24       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.